BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Zhu P, Qiu J, Wang J, Zhu H, Zhu Y, Zhang L, Zhu J, Liu X, Dong C. Identification and characterization of interferon signaling-related microRNAs in occult hepatitis B virus infection. Clin Epigenetics. 2017;9:101. [PMID: 28932321 DOI: 10.1186/s13148-017-0404-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Hao QQ, Wang QH, Xia W, Qian HZ. Circulating miRNA expression profile and bioinformatics analysis in patients with occult hepatitis B virus infection. J Med Virol 2020;92:191-200. [PMID: 31513283 DOI: 10.1002/jmv.25594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
2 Hao Q, Wang Q, Qian H, Jiang J, Liu X, Xia W. Identification and functional characterization of miR-451a as a novel plasma-based biomarker for occult hepatitis B virus infection. Microb Pathog 2021;161:105233. [PMID: 34626767 DOI: 10.1016/j.micpath.2021.105233] [Reference Citation Analysis]
3 Dai M, Li L, Qin X. Clinical value of miRNA-122 in the diagnosis and prognosis of various types of cancer. Oncol Lett 2019;17:3919-29. [PMID: 30881509 DOI: 10.3892/ol.2019.10024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
4 Wu J, Liu X, Shao J, Zhang Y, Lu R, Xue H, Xu Y, Wang L, Zhou H, Yu L, Yue M, Dong C. Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response. Virol J 2021;18:244. [PMID: 34876159 DOI: 10.1186/s12985-021-01717-7] [Reference Citation Analysis]
5 Zhou X, Fang S, Wang M, Xiong A, Zheng C, Wang J, Yin C. Diagnostic value of circulating miRNA-122 for hepatitis B virus and/or hepatitis C virus-associated chronic viral hepatitis. Biosci Rep 2019;39:BSR20190900. [PMID: 31427483 DOI: 10.1042/BSR20190900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Hao Q, Wang Z, Wang Q, Chen B, Qian H, Liu X, Cao H, Xia W, Jiang J, Lu Z. Identification and characterization of lncRNA AP000253 in occult hepatitis B virus infection. Virol J 2021;18:125. [PMID: 34112188 DOI: 10.1186/s12985-021-01596-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bakshi S, Kaur M, Saini N, Mir AA, Duseja A, Sinha SK, Sharma S. Altered expressions of circulating microRNAs 122 and 192 during antitubercular drug induced liver injury indicating their role as potential biomarkers. Hum Exp Toxicol 2021;40:1474-84. [PMID: 33729026 DOI: 10.1177/0960327121997975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Iacob DG, Rosca A, Ruta SM. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World J Gastroenterol 2020; 26(11): 1113-1127 [PMID: 32231417 DOI: 10.3748/wjg.v26.i11.1113] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
9 Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, Kramvis A. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019;8:E1504. [PMID: 31771261 DOI: 10.3390/cells8121504] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]